Showing 1171-1180 of 1616 results for "".
- Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websiteshttps://modernod.com/news/ace-vision-group-adds-four-ophthalmologists-to-medical-advisory-board-launches-new-corporate-and-medical-affairs-websites/2481941/Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for e
- Visus Therapeutics Expands Clinical Advisory Board With Appointment of Renowned Ophthalmologistshttps://modernod.com/news/visus-therapeutics-expands-clinical-advisory-board-with-appointment-of-renowned-ophthalmologists/2478453/Visus Therapeutics announced the appointments of prominent ophthalmologists Marguerite McDonald, MD, Neda Shamie, MD, William Trattler, MD, and Lawrence Woodard, MD, to its clinical advisory board. Drs. McDonald, Shamie, Trattler and Woodard will lend their decades of experience in clinical pract
- Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19’s Impacthttps://modernod.com/news/covid-19-forecasting-the-new-normal/2477626/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, were joined by Iqbal Ike K. Ahmed, MD, FRCSC; John Kitchens, MD; and Justin Schweitzer, OD, to discuss COVID-19’s impact across eye care and share their predictions for how the current
- New Podcast Addresses COVID-19 Impacthttps://modernod.com/news/new-podcast-addresses-covid-19-impact/2477431/In the latest installment of the Off the Grid podcast, titled “Unprecedented Times,” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, speak with Steven J. Dell, MD, and Tal Raviv, MD, to discuss the novel coronavirus and its impact on their respective states, practices, and dail
- Oculis Appoints Snehal Shah, PharmD, as President of Research & Developmenthttps://modernod.com/news/oculis-appoints-snehal-shah-pharmd-as-president-of-research-development/2482225/Oculis announced the appointment of Snehal Shah, PharmD, executive leader with over two decades of research & development (R&D) and regulatory experience, to the role of President of R&D. In this new role, Dr. Shah will be responsible for leading research and developmen
- Early Study Shows J&J’s One-Dose COVID-19 Vaccine Triggered Antibodies in all Participantshttps://modernod.com/news/early-study-shows-jjs-one-dose-covid-19-vaccine-triggered-antibodies-in-all-participants/2478759/Detailed phase 1/2a study findings published in the NEJM on Wednesday showed that all volunteers given Johnson & Johnson’s single-dose coronavirus vaccine Ad26.COV2.S had detectable neutralizing antibodies by day 57. In September, the company reported a preview of the interim results in
- Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in MGDhttps://modernod.com/news/azura-ophthalmics-presents-positive-results-from-phase-2b-clinical-trial-of-azr-md-001-in-meibomian-gland-dysfunction/2481286/Azura Ophthalmics announced that positive 3-month efficacy and safety results from its
- Eyewire News Exclusive: Q&A With Anne Coleman, MD, PhD, President of AAOhttps://modernod.com/news/eyewire-news-exclusive-qa-with-anne-coleman-md-phd-president-of-aao/2477474/The American Academy of Ophthalmology (AAO) continues to update its guidance for ophthalmologists dealing with the COVID-19 pandemic. Most recently, AAO updated its guidance on vaccine and t
- CMS Finalizes Plan to Allow Medicare Advantage Plans to Expand Telehealth Benefitshttps://modernod.com/news/cms-finalizes-plan-to-allow-medicare-advantage-plans-to-expand-telehealth-benefits/2477820/The Trump administration has finalized several changes in Medicare Advantage (MA) and Part D in anticipation of bid submissions on June 1, according to a FierceHealthcare
- Ocular Therapeutix Announces Board of Directors and Leadership Updateshttps://modernod.com/news/ocular-therapeutix-announces-board-of-directors-and-leadership-updates/2482128/Ocular Therapeutix announced Board of Directors and leadership updates with the addition of Pravin U. Dugel, MD as Executive Chairman; and the additions of Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD, to the Ocular management